Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 933 results for "hepatitis"

376 images for hepatitis

Daily Newswatch, 1 day ago
Hepatology, 23 hours ago
American Journal of Hematology, 1 day ago
Hepatology, 1 day ago
Hepatology, 1 day ago, 4 days ago
Physicians News Digest, 2 days ago
Med India, 1 week ago
Med India, 1 week ago
Med India, 1 week ago
Daily Newswatch

Hep B treatment for mums protects infants

Doctors are being encouraged to offer antiviral treatment to expectant mothers with high levels of hepatitis B virus to protect their infants from acquiring the infection. Research presented at Australian Gastroenterology Week shows mothers ... hours ago Treating hepatitis with diet  Daily Newswatch1 day ago VIDEO: Hepatitis C Screening Rises, But Where Are the Positive Cases?  Clinician Reviews2 days ago Estimating the Number of Patients with Chronic Hepatitis C (HCV) Infection Meeting 'Highest' or 'High' Priority Treatment Criteria in the United States  National AIDS Treatment Advocacy Project3 days ago
Philippine Daily Inquirer

Survivor of 4 brods determined to fight liver cancer

He lost all of his siblings to liver cancer caused by hepatitis B in a five-year period, from 2008 to 2013. Today, he is in danger of losing his own life, having been diagnosed late last year with the same dreaded disease which decimated his family.
 Philippine Daily Inquirer15 hours ago Key factor discovered in progression of liver cancer  Science Daily2 days ago Key factor discovered in the progression of liver cancer  Ecancer Medicalscience1 day ago
Motley Fool

This May Be the Fastest Growing Big Biotech Stock Next Year (Hint: It's Not Gilead Sciences)

Rapidly rising Gilead Sciences is the leading maker of HIV and hepatitis C drugs, and those drugs have catapulted Gilead Science's revenue and profit significantly higher this year. Revenue from Gilead Science's HIV therapies is up 12% to more than ...
 Motley Fool18 hours ago
Bidness Etc

AbbVie (ABBV) Hepatitis C Drugs Win The Nod Of European Regulators

AbbVies all-new experimental hepatitis C drugs have been recommended for approval by the European Medicines Agency, sending the stock up over 3% Page 1 of 2 Click Ticker to See live coverage AbbVie Inc ( NYSE: ABBV ) stock rose 3.3% ...
 Bidness Etc1 day ago Europe gives green light to AbbVie hepatitis C medicine, others  Yahoo! Finance2 days ago Stock Update: AbbVie Inc (NYSE:ABBV) Europe gives green light to AbbVie hepatitis C medicine, others  Tamar Securities1 day ago AbbVie gets an EU green light for its next-gen hep C treatment  FierceBiotech1 day ago

EMA Panel Backs Exviera, Viekirax for Chronic Hepatitis C

Dasabuvir ( Exviera , AbbVie) and ombitasvir + paritaprevir + ritonavir ( Viekirax , AbbVie) were recommended by the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) for the treatment of adults with chronic ...
 Medscape1 day ago AbbVie's hepatitis C regimen combining Viekirax, Exviera recommended for clearance in EU  FirstWord Pharma1 day ago AbbVie's hepatitis C therapies Exviera, Viekirax recommended for clearance in EU  FirstWord Pharma2 days ago EMA unit backs new hep C drugs Exviera and Viekirax from AbbVie  Pharma Letter22 hours ago

Pharma drugs advance in EU

The EU's medical advisory committee endorsed OK'ing AbbVie's (ABBV) all-oral hepatitis C combo Viekirax and Exviera for genotype 1 of hepatitis C, with or without the generic drug ribavirin. The committee also endorsed the combo with ribavirin for ...
 Yahoo! Finance1 day ago AbbVie, Celgene, Sanofi Drugs Get EU Endorsements  Investor's Business Daily1 day ago

News and press releases: Two new medicines recommended for the treatment of chronic hepatitis C

21/11/2014 Two new medicines recommended for the treatment of chronic hepatitis C Additional treatment options with high cure rates to be available to patients The European Medicines Agency (EMA) has recommended a marketing ...
 European Medicines Agency1 day ago Two new medicines recommended for the treatment of chronic hepatitis C  FierceBiotech1 day ago

France Strikes Deal For Gilead Sciences, Inc. (GILD)'s Hep C Drug Sovaldi 11/21/2014

Sovaldi, the most expensive Hepatitis C drug developed by Gilead Sciences is now available in France for a lower price. France insisted that they would tax Gilead if they keep on selling their Hepatitis C drug on its current price, which costs an ...
 ClinicSpace1 day ago French Government Negotiates a Deal With Gilead for Sovaldi  American Journal of Managed Care1 day ago France pegs Gilead hepatitis C drug at "lowest price in Europe"  Yahoo! Finance3 days ago 2014: Gilead raking in massive cash from hepatitis C drug Sovaldi  SiliconValley.com3 days ago

Hepatitis D-Pipeline Insights, 2014

SUMMARY ' ', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hepatitis D. This report provides ...
 Individual.com6 days ago Hepatic - Colorectal Metastasis-Pipeline Insights, 2014  Individual.com6 days ago Hepatitis A-Pipeline Insights, 2014  Individual.com6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less